A divergent synthetic approach to diverse molecular scaffolds: assessment of lead-likeness using LLAMA, an open-access computational tool.

Complementary cyclisation reactions of hex-2-ene-1,6-diamine derivatives were exploited in the synthesis of alternative molecular scaffolds. The value of the synthetic approach was analysed using LLAMA, an open-access computational tool for assessing the lead-likeness and novelty of molecular scaffolds.

[1]  M. E. González-Rosende,et al.  1,3-Oxazin-2-ones vs tetrahydrofurans by iodocyclisation of 2-alkoxycarbonylamino-3-alken-1-ols , 2000 .

[2]  Emanuele Perola,et al.  An analysis of the binding efficiencies of drugs and their leads in successful drug discovery programs. , 2010, Journal of medicinal chemistry.

[3]  O. Grygorenko,et al.  Toward lead-oriented synthesis: one-pot version of Castagnoli condensation with nonactivated alicyclic anhydrides. , 2014, ACS combinatorial science.

[4]  Wolfgang H. B. Sauer,et al.  Molecular Shape Diversity of Combinatorial Libraries: A Prerequisite for Broad Bioactivity , 2003, J. Chem. Inf. Comput. Sci..

[5]  F. Amiot,et al.  Synthesis of enantiopure substituted aziridines by diastereoselective N-bromocyclization and nucleophile-mediated regioselective opening , 1998 .

[6]  A. H. Lipkus,et al.  Structural Diversity of Organic Chemistry. a Scaffold Analysis of the Cas Registry , 2022 .

[7]  William Lewis,et al.  Synthesis of natural-product-like scaffolds in unprecedented efficiency via a 12-fold branching pathway , 2011 .

[8]  M. Pilátová,et al.  The convergent total synthesis of cytotoxic homospisulosine and its 3- epi -analogue , 2015 .

[9]  G. V. Paolini,et al.  Quantifying the chemical beauty of drugs. , 2012, Nature chemistry.

[10]  Adam Nelson,et al.  A unified lead-oriented synthesis of over fifty molecular scaffolds. , 2015, Organic & biomolecular chemistry.

[11]  P. Leeson,et al.  A comparison of physiochemical property profiles of development and marketed oral drugs. , 2003, Journal of medicinal chemistry.

[12]  J. A. Grant,et al.  A modular lead-oriented synthesis of diverse piperazine, 1,4-diazepane and 1,5-diazocane scaffolds. , 2014, Organic & biomolecular chemistry.

[13]  Andrew C. Flick,et al.  Rhodium(II)-catalyzed aziridination of allyl-substituted sulfonamides and carbamates. , 2004, The Journal of organic chemistry.

[14]  M. Waring.  Defining optimum lipophilicity and molecular weight ranges for drug candidates-Molecular weight dependent lower logD limits based on permeability. , 2009, Bioorganic & medicinal chemistry letters.

[15]  Adam Nelson,et al.  A systematic approach to diverse, lead-like scaffolds from α,α-disubstituted amino acids. , 2015, Chemical communications.

[16]  J. Wolfe,et al.  Mild conditions for Pd-catalyzed carboamination of N-protected hex-4-enylamines and 1-, 3-, and 4-substituted pent-4-enylamines. Scope, limitations, and mechanism of pyrrolidine formation. , 2008, The Journal of organic chemistry.

[17]  Tudor I. Oprea,et al.  Is There a Difference between Leads and Drugs? A Historical Perspective , 2001, J. Chem. Inf. Comput. Sci..

[18]  Peter O'Brien,et al.  Lead-oriented synthesis: Investigation of organolithium-mediated routes to 3-D scaffolds and 3-D shape analysis of a virtual lead-like library. , 2015, Bioorganic & medicinal chemistry.

[19]  J. A. Grant,et al.  Modular, gold-catalyzed approach to the synthesis of lead-like piperazine scaffolds. , 2013, Organic letters.

[20]  G. Bemis,et al.  The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.

[21]  J. Bats,et al.  Synthesis of the Bicyclic Core of Pumiliotoxins , 2002 .

[22]  M. Hann.  Molecular obesity, potency and other addictions in drug discovery , 2011 .

[23]  Ryan G. Coleman,et al.  ZINC: A Free Tool to Discover Chemistry for Biology , 2012, J. Chem. Inf. Model..

[24]  György M. Keserü,et al.  The influence of lead discovery strategies on the properties of drug candidates , 2009, Nature Reviews Drug Discovery.

[25]  S. Knapp,et al.  Synthesis of the oxygenated pactamycin core. , 2007, Organic letters.

[26]  Adam Nelson,et al.  A conceptual framework for analysing and planning synthetic approaches to diverse lead-like scaffolds. , 2013, Chemical communications.

[27]  C. Lipinski.  Lead- and drug-like compounds: the rule-of-five revolution. , 2004, Drug discovery today. Technologies.

[28]  M. Ohno,et al.  Stereocontrolled synthesis of 6-epi-D-purpurosamine B by iodocyclocarbamation of a chiral Z-olefin derived from L-alanine and L-malic acid , 1987 .

[29]  P. Leeson,et al.  The influence of drug-like concepts on decision-making in medicinal chemistry , 2007, Nature Reviews Drug Discovery.

[30]  Adam Nelson,et al.  Towards the realisation of lead-oriented synthesis. , 2014, Drug discovery today.

[31]  C. Humblet,et al.  Escape from flatland: increasing saturation as an approach to improving clinical success. , 2009, Journal of medicinal chemistry.

[32]  Alexander Chuprina,et al.  Drug- and Lead-likeness, Target Class, and Molecular Diversity Analysis of 7.9 Million Commercially Available Organic Compounds Provided by 29 Suppliers , 2010, J. Chem. Inf. Model..

[33]  Channa K. Hattotuwagama,et al.  Lead-oriented synthesis: a new opportunity for synthetic chemistry. , 2012, Angewandte Chemie.

[34]  T. Chou,et al.  Staurosporine and ent-Staurosporine: The First Total Syntheses, Prospects for a Regioselective Approach, and Activity Profiles1 , 1996 .

[35]  Nathan Brown,et al.  Plane of Best Fit: A Novel Method to Characterize the Three-Dimensionality of Molecules , 2012, J. Chem. Inf. Model..

[36]  T. Ritchie,et al.  The impact of aromatic ring count on compound developability--are too many aromatic rings a liability in drug design? , 2009, Drug discovery today.

[37]  A. Wee,et al.  Stereoselective synthesis of the nonproteinogenic amino acid (2S,3R)-3-amino-2-hydroxydecanoic acid from (4S,5S)-4-formyl-5-vinyl-2-oxazolidinone. , 2003, The Journal of organic chemistry.

[38]  S. Davies,et al.  Syntheses of derivatives of L-daunosamine and its C-3 epimer employing as the key step the asymmetric conjugate addition of a homochiral lithium amide to tert-butyl (E,E)-hexa-2,4-dienoate , 1999 .